Zhao, X., Liu, Z., Xu, J., Liu, G. (2025). CD5 positivity and aberrant P53 expression predict primary refractoriness to first-line pola-R-CHP in patients with diffuse large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-1887